Physician profile
Otis A Barron
NPI 1033264031
$122,477.12
in general payments reported to CMS, 2019-2025
10 companies · $24K in 2025
The $24K reported for 2025 was more than what 96% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $21K · 2022: $18K · 2023: $18K · 2024: $17K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $57K · Food and Beverage: $409 · Travel and Lodging: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $57,338.00 |
| Food and Beverage | $408.76 |
| Travel and Lodging | $269.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $121,074.00 | 2019-2025 | Xmcp |
| Anika Therapeutics, INC. | $438.84 | 2024 | Revomotion |
| Medartis INC. | $372.35 | 2019-2021 | |
| Stryker Corporation | $157.57 | 2022 | |
| Skeletal Dynamics INC | $135.00 | 2023 | Implate, Align, Ijs |
| Endo Pharmaceuticals INC. | $125.00 | 2021 | |
| Axogen | $74.36 | 2025 | |
| Djo, LLC | $49.80 | 2022 | |
| Globus Medical, INC. | $29.90 | 2024 | Distal Radius II |
| Bioventus LLC | $20.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Otis Barron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.